Lymphoma Research Foundation – Targeted Therapies in CLL/SLL: Treatment Sequencing and Adverse Events Management

Targeted Therapies in CLL/SLL: Treatment Sequencing and Adverse Events Management
This activity will provide learners with insights and analysis of the clinical implications of new and emerging data for minimizing treatment-emergent adverse events and managing treatment sequencing decisions in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.